RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Current drug targets in obesity pharmacotherapy–a review

Current drug targets in obesity pharmacotherapy–a review

Add to Collection
Review SP Bhat, A Sharma - Current drug targets, 2017 - ingentaconnect.com

Chapter : Section3
Journal Year : 2017
Cited by : 48.0

… both type 1 and type 2 diabetes [7]. It also … diabetes [37]. In clinical trials, pramlintide showed greater weight loss in people with higher baseline BMI (type 2 diabetes) and in non-diabetic …..... Read More

Keywords : ["obesity pharmacotherapya review", "current drug target"]
PubMed Link : https://www.ingentaconnect.com/content/ben/cdt/2017/00000018/00000008/art00012
Google Scholar Link : https://scholar.google.com/scholar?cites=15614454427515078257&as_sdt=5,25&sciodt=0,25&hl=en&num=20